Czech Doctors Prescribed 318.7 Kilograms of Cannabis in 2024
The use of medicinal cannabis continues to expand in the Czech Republic, with doctors prescribing a record 318.7 kilograms in 2024, according to data from Czechia’s State Institute for Drug Control. This marks a significant increase from previous years and reflects growing acceptance and accessibility of cannabis for patients in the country.
Steady Growth in Patient Numbers and Prescriptions
Over the past four years, the amount of prescribed medicinal cannabis in Czechia has risen substantially:
- 2021: 109.4 kilograms
- 2022: 157.4 kilograms
- 2023: 258.8 kilograms
- 2024: 318.7 kilograms
Alongside the increase in prescribed amounts, the number of patients using medicinal cannabis has also grown. In 2023, an average of 2,570 patients were prescribed cannabis per month, a number that has now risen to approximately 3,300 in 2024.
Upcoming Policy Changes in April 2025
In a move that is expected to further expand access, new regulations taking effect in April 2025 will allow general practitioners (GPs) to prescribe cannabis for chronic pain. Additionally, patients will be able to receive up to a three-month supply per prescription, making it easier for individuals to manage their treatment.
Broader Cannabis Policy Reforms in Czechia
Beyond medicinal cannabis, the Czech government has been working on broader cannabis reforms. In November 2024, the Czech cabinet approved a plan that would permit adults to cultivate up to three cannabis plants at home and possess up to 50 grams of cannabis for personal use.
However, some politicians and cannabis advocates argue that the policy changes do not go far enough. Critics, such as members of the Czech Pirate Party, have pointed out inconsistencies in the proposed legislation. For example, while cultivation will be allowed, strict possession limits could create enforcement challenges.
Regulation of Low-THC Cannabis and Kratom
Another significant policy shift will take effect in July 2025, when the Czech government will regulate sales of cannabis products containing up to 1% THC.
This will allow licensed stores to sell certain cannabis extracts and tinctures with minimal psychoactive effects. The same regulations will also apply to kratom, a plant-based product commonly used for its stimulant-like effects.
Personal Perspective
The steady rise in medicinal cannabis prescriptions in Czechia highlights the growing recognition of its benefits among both patients and healthcare professionals. The upcoming policy changes allowing GPs to prescribe cannabis for chronic pain are a positive step, as they will likely increase access for those who need it most.
However, the broader cannabis reform proposals remain a topic of debate. While the allowance for home cultivation is a move in the right direction, the restrictive possession limits could create unnecessary legal complications.
It will be interesting to see how these regulations evolve as public opinion and scientific research continue to shape cannabis policy in Czechia.
